Gene · 29949
Papers1,818
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 1,818
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease. | Front Med (Lausanne) | 2021 | 34869409 | PubTator, text mining | PubMed |
| IL-22 Binding Protein (IL-22BP) in the Regulation of IL-22 Biology. | Front Immunol | 2021 | 34868019 | PubTator, text mining | PubMed |
| Copy Number Variation Analysis of IL22 and LCE3C in Different Subtypes of Psoriasis in a Chinese Han Population. | Med Sci Monit | 2021 | 34853291 | PubTator, text mining | PubMed |
| Innate-Immunity Genes in Obesity. | J Pers Med | 2021 | 34834553 | PubTator, text mining | PubMed |
| Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease. | Pharmaceutics | 2021 | 34834201 | PubTator, text mining | PubMed |
| Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation. | Cells | 2021 | 34831399 | PubTator, text mining | PubMed |
| Use of Cytokine Mix-, Imiquimod-, and Serum-Induced Monoculture and Lipopolysaccharide- and Interferon Gamma-Treated Co-Culture to Establish In Vitro Psoriasis-like Inflammation Models. | Cells | 2021 | 34831208 | PubTator, text mining | PubMed |
| Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients. | Healthcare (Basel) | 2021 | 34828623 | PubTator, text mining | PubMed |
| Assessment of the usefulness of prognostic Van Nuys Prognostic Index in the treatment in ductal carcinoma in situ in 15-year observation. | Sci Rep | 2021 | 34811426 | PubTator, text mining | PubMed |
| TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy. | Sci Immunol | 2021 | 34797693 | PubTator, text mining | PubMed |
| Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells. | iScience | 2021 | 34786537 | PubTator, text mining | PubMed |
| Current Concepts of Psoriasis Immunopathogenesis. | Int J Mol Sci | 2021 | 34769005 | PubTator, text mining | PubMed |
| Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosis. | Clin Transl Immunology | 2021 | 34765193 | PubTator, text mining | PubMed |
| Evaluation of the relationship between anti-inflammatory cytokines and adverse cardiac remodeling after myocardial infarction. | Kardiologiia | 2021 | 34763640 | PubTator, text mining | PubMed |
| Interleukin-22 Deficiency Contributes to Dextran Sulfate Sodium-Induced Inflammation in Japanese Medaka, Oryzias latipes. | Front Immunol | 2021 | 34759916 | PubTator, text mining | PubMed |
| Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis. | Acta Neuropathol Commun | 2021 | 34758873 | PubTator, text mining | PubMed |
| Age-Specific Etiology of Severe Acute Respiratory Infections and Influenza Vaccine Effectivity in Prevention of Hospitalization in Russia, 2018-2019 Season. | J Epidemiol Glob Health | 2021 | 34734387 | PubTator, text mining | PubMed |
| Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress. | Adv Ther (Weinh) | 2021 | 34734110 | PubTator, text mining | PubMed |
| Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer. | Cancer Med | 2021 | 34729947 | PubTator, text mining | PubMed |
| Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion. | Semin Immunol | 2021 | 34728121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29949/papers?page=30